Diabetic microangiopathic complications in young Chinese diabetic patients: A clinic-based cross-sectional study

Journal of Diabetes and its Complications

Volumn 13, Issue 5-6, 1999, Pages 300-306

  Ko, Gary T C ^a   Chan, Juliana C N ^a   Lau, Maggie ^a   Cockram, Clive S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEINURIA; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 0033549913     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(99)00063-X     Document Type: Article

References (24)

1. Kokkonen J., Laatikainen L., van Dickhoff K., Miettinen R., Tuominen M., Lautala P., Salmela P. Ocular complications in young adults with insulin-dependent diabetes mellitus since childhood. Acta Paediatr. 83:1994;273-278.
2. Klein R., Klein B.E.K., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 102:1984;520-526.
3. Chiumello G., Bognetti E., Meschi F., Carra M., Balzano E. Early diagnosis of subclinical complications in insulin dependent diabetic children and adolescents. J Endocrinol Invest. 12:1989;101-104.
4. Ficicioglu C., Aydin A., Haktan M., Kiziltan M. Peripheral neuropathy in children with insulin-dependent diabetes mellitus. Turk J Pediatr. 36:1994;97-104.
5. McNally P.G., Burden A.C., Swift P.G., Walls J., Hearnshaw J.R. The prevalence and risk factors associated with the onset of diabetic nephropathy in juvenile-onset diabetics diagnosed under the age of 17 years in Leicestershire 1930-1985. Q J Med. 76:1990;831-844.
6. Joner G., Brinchmann-Hansen O., Torres C.G., Hanssen K.F. A nation-wide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 diabetic patients. Diabetologia. 35:1992;1049-1054.
7. Kalter-Leibovici O., Van Dyk D.J., Leibovici L., Loya N., Erman A., Kremer I., Boner G., Rosenfeld J.B., Karp M., Laron Z. Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes. 40:1991;204-210.
8. Parving H.H., Andersen A.R., Smidt U.M., Christiansen J.S., Oxenboll B., Svendsen P.A. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes. 32:1983;83-87.
9. Chan J.C.N., Cheung C.K., Swaminathan R., Nichols M.G., Cockram C.S. Obesity, albuminuria and hypertension among Hong Kong Chinese with NIDDM. Postgrad Med J. 69:1993;204-210.
10. Dowse G.K., Zimmet P.Z., Gareeboo H., George K., Alberti M.M., Tuomilehto J., Finch C.F., Chitson P., Tulsidas H. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diabetes Care. 14:1991;271-282.
11. Friedewald W.T., Levy R.I., Fredrickason D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
12. Laakso M., Pyorala R.E. Age of onset and type of diabetes. Diabetes Care. 8:1985;114-117.
13. Madsbad S., Krarup T., McNair P., Christiansen C., Fabert O.K., Transbol O.K.et al. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand. 210:1981;153-156.
14. Mogensen C.E., Vestbo E., Poulsen P.L., Christiansen C., Damsgaard E.M., Eiskjaer H.et al. Microalbuminuria and potential confounders. Diabetes Care. 18:1995;572-581.
15. Liniger C., Albeanu A., Bloise D., Assal J.P.H. The tuning fork revisited. Diabetic Med. 7:1990;859-864.
16. Kuczmarski R.J., Flegal K.M., Campbell S.M., Johnson C.L. Increasing prevalence of obesity among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 272:1994;205-211.
17. Nelson R.G., Kunzelman C.L., Pettitt D.J., Saad M.F., Bennett P.H., Knowler W.C. Albuminuria in NIDDM and glucose tolerance in Pima Indians. Diabetologia. 32:1989;870-876.
18. Parving H.H., Hommel E., Mathiesen E., Skott P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P., Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J. 296:1988;156-160.
19. Ko G.T.C., Chan J.C.N., Woo J., Lau E., Yeung V.T.F., Chow C.C.et al. Simple anthropometric indexes and cardiovascular risk factors in Chinese. Int J Obesity. 21:1997;995-1001.
20. Chan J.C.N., Tomlinson B., Nicholls M.G., Swaminathan R., Cheung C.K., Woo J.et al. Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with NIDDM. Diabetic Med. 13:1996;150-155.
21. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
22. The effect of intensive treatment of diabetes on the development and progression of long-term complications in IDDM. N Engl J Med. 329:1993;977-986.
23. Klein R., Klein B.E.K., Moss S.E., David M.D., De Mets D.L. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med. 149:1989;2427-2432.
24. Chase H.P., Garg S.K., Marshall G., Berg C.L., Harris S., Jackson W.E.et al. Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA. 265:1991;614-617.